Both in Pharmaceuticals
Acurx Pharmaceuticals vs Processa Pharmaceuticals
Over the past year ACXP returned −81.2% and PCSA returned −80.6%; their daily moves had a correlation of 0.04.
ACXP −81.2% PCSA −80.6%Growth of $1, one year, split-adjusted
| Metric | ACXP | PCSA |
|---|---|---|
| Price | $1.07 | $1.89 |
| Market cap | $5.9M | $5.3M |
| Today | 0.00% | +2.16% |
| 1 month | −15.1% | +15.2% |
| 6 months | −50.5% | −30.0% |
| Year to date | −57.0% | −34.4% |
| 1 year | −83.0% | −76.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.7M | $196.3K |
| Dividend yield | — | — |
| Volatility (60d) | 60.1% | 90.7% |
| Short % of float | 1.8% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).